-+ 0.00%
-+ 0.00%
-+ 0.00%

Simulations Plus partners with global pharma company on AI-enabled QSP modeling using Turin

PUBT·10/08/2026 13:15:26
Listen to the news
Simulations Plus partners with global pharma company on AI-enabled QSP modeling using Turin
  • Simulations Plus entered a funded partnership with a large global pharmaceutical company to deploy its Turin AI engine in an active drug program.
  • Collaboration aims to cut QSP model build and evaluation timelines by scaling exploration of mechanistic model structures.
  • Pharma partner will run Turin in a hosted environment with support from Simulations Plus scientists during model evaluation.
  • Agreement targets broader use of QSP in model-informed drug development, with plans to expand into additional therapeutic programs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simulations Plus Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610080915BIZWIRE_USPR_____20261008_BW831077) on October 08, 2026, and is solely responsible for the information contained therein.